WINTW Windtree Therapeutics (PNK) up 466.67% on 30 Jan 2026: thin-volume move to monitor
Today’s top gainer, WINTW stock (Windtree Therapeutics, Inc., PNK), rose to $0.01 intraday on 30 Jan 2026 after a one-day move of 466.67% from a prior close of $0.0015. The jump follows extremely thin liquidity and a low float, not a confirmed new corporate disclosure. We use Meyka AI’s market tools to parse price action, volume, fundamentals and the clinical program backdrop for this US-listed biotech.
WINTW stock: intraday price action and market facts
WINTW stock traded at $0.0085 at the latest print, up $0.0070 or 466.67% on 30 Jan 2026. Volume was 1,000 shares versus an average volume of 28,274, showing a relative volume of 0.04. The company trades on the PNK exchange in the United States and has 296,905,440 shares outstanding and a market cap near USD 289,000.
Drivers behind the move and sector context for WINTW stock
No major press release or earnings surprise was recorded with this spike, so the gain likely reflects microcap volatility and low liquidity. One-day rises from a $0.0015 base can appear large in percent terms even on small dollar flows.
Windtree operates in the Healthcare / Biotechnology sector. Sector trends can amplify small-cap swings, but broader biotech indices showed muted moves today, suggesting this was idiosyncratic to WINTW stock.
Fundamentals and valuation snapshot for WINTW stock
Windtree Therapeutics reports clinical-stage programs including istaroxime and AEROSURF. The company has minimal operating revenue and negative book value. Key metrics: cash per share USD 7.65, revenuePerShare TTM USD 3.37, priceAvg50 USD 0.02, and priceAvg200 USD 0.02. Current ratio is 0.33, showing tight short-term liquidity.
Valuation multiples are not meaningful: EPS and P/E are null. Enterprise value measures and EV/Sales are skewed by low market cap and reported enterprise value. These figures signal a speculative profile for WINTW stock rather than a value play.
Technical setup and trading risks for WINTW stock
Technical indicators show limited confirmation. RSI is 37.08, MACD near -0.01, and ADX 23.60. The 50-day and 200-day averages sit near $0.02, above the current quote. This is a short-term pop without broad technical support.
Trading risks include wide bid-ask spreads, low depth, and potential for rapid reversal. Average volume is 28,274 but today’s volume was only 1,000, increasing execution risk for larger orders in WINTW stock.
Meyka AI rates WINTW with a score out of 100 and forecasts
Meyka AI rates WINTW with a score of 62.65 out of 100 — Grade B, Suggestion: HOLD. This grade factors in S&P 500 comparison, sector and industry benchmarks, financial growth, key metrics, forecasts, and analyst consensus. These grades are not guaranteed and we are not financial advisors.
Meyka AI’s forecast model projects monthly USD 0.01 and quarterly USD 0.04 for WINTW stock compared with the current price USD 0.0085. The implied upside is 17.65% to the monthly projection and 370.59% to the quarterly projection. Forecasts are model-based projections and not guarantees.
Trading strategy and practical watchlist levels for WINTW stock
For traders focused on top gainers, use clear size limits and limit orders. Conservative short-term target: USD 0.02. Aggressive target for momentum traders: USD 0.05. Consider a protective stop at USD 0.0040 given the high volatility.
Because WINTW stock trades on PNK in the United States and carries speculative fundamentals, position sizing and risk controls are essential for any trade or watchlist entry.
Final Thoughts
WINTW stock recorded a dramatic intraday percentage gain on 30 Jan 2026 driven by extreme low-price math and thin liquidity rather than a clear operational catalyst. The latest quote of USD 0.0085 contrasts with a prior close of USD 0.0015, so percent moves look large despite modest cash flow. Fundamental metrics show negative book value, a current ratio of 0.33, and minimal earnings visibility. Meyka AI rates WINTW with a score of 62.65/100 (Grade B, HOLD) and projects USD 0.01 monthly and USD 0.04 quarterly. Those forecasts imply +17.65% and +370.59% from the current price, respectively. These model outputs are not guarantees. Investors should treat WINTW stock as a high-risk microcap. If you trade the name, use tight position limits, limit orders, and monitor regulatory news or clinical updates closely. For more details, see the company site and our stock page on Meyka AI for live feeds and alerts.
FAQs
Why did WINTW stock spike today?
The spike reflects a low prior base price and thin liquidity, not a confirmed corporate announcement. Microcap flows and order imbalances can produce outsized percent moves in WINTW stock.
What is Meyka AI’s view on WINTW stock?
Meyka AI rates WINTW with 62.65/100, Grade B (HOLD). The model shows a monthly forecast of USD 0.01 and a quarterly forecast of USD 0.04, but these are projections, not guarantees.
What are practical trade levels for WINTW stock?
Short-term conservative target USD 0.02, aggressive target USD 0.05, and a protective stop near USD 0.0040. Use small sizes and limit orders due to low depth.
Does Windtree pay dividends or show profits?
No. Windtree reports no dividend yield and negative net income metrics. EPS and P/E are not meaningful for WINTW stock given its clinical-stage status.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
